highly significantp < 0.001
This immunoreactivity became intense and widespread across the COVID-19 infected group, with highly significant differences ( p < 0.001) compared with the control group (Fig. 11 b).
This immunoreactivity became intense and widespread across the COVID-19 infected group, with highly significant differences ( p < 0.001) compared with the control group (Fig. 11 b).